Lv11
90 积分 2024-11-12 加入
In vivo CAR T cell generation to treat cancer and autoimmune disease
6小时前
待确认
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
1个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
1个月前
已关闭
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
1个月前
已完结
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
2个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
3个月前
已关闭
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
3个月前
已完结
Phase I Trial of MCARH109, a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)–Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
3个月前
已完结
皖公网安备34019202002308
